Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1858523

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1858523

Blood Gas Analyzer Market by Product (Consumables, Services), Type of Testing (PoC, Conventional), Sample (Arterial, Venous, Capillary Blood), Application (Respiratory, Emergency Care Management), End User (Hospitals, Clinics) - Global Forecast to 2030

PUBLISHED:
PAGES: 281 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

The market was valued at approximately USD 2.70 billion in 2025 and is projected to reach USD 3.38 billion by 2030, growing at a CAGR of 4.6% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsProduct, Type of Testing, Sample Type, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

The market is witnessing strong growth due to the rising demand for rapid patient assessment in hospital and critical care settings, the need for continuous monitoring of acid-base balance and oxygenation in at-risk patients, and increasing healthcare spending in emerging regions. Additionally, supportive government initiatives to improve hospital diagnostic capabilities and streamline patient care further drive the adoption of blood gas analyzers worldwide.

Blood Gas Analyzer Market - IMG1

The consumables segment accounted for the largest share of the blood gas analyzer market, by product in 2024.

The blood gas analyzer market is segmented into consumables, analyzers, and services based on product. In 2024, the consumables segment held the largest share of the market, as consumables are required for every test performed. The recurring demand for consumables in hospitals, ambulatory care settings, and clinics is a key factor driving the segment's growth.

Hospitals & ASCs segment accounted for the largest share of the blood gas analyzer market, by end user in 2024.

The blood gas analyzer market is segmented by end user into Hospitals and ASCs, Clinics, and Other End Users. In 2024, Hospitals and ASCs accounted for the largest market share, as these facilities frequently test blood gas for critically ill patients and those undergoing complex procedures. The high patient volumes and the need for continuous monitoring in these settings drive substantial demand for blood gas analyzers.

Asia Pacific is expected to be the fastest-growing region in the blood gas analyzer market.

The global blood gas analyzer market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience the highest growth during the forecast period. Emerging economies in this region are seeing consistent GDP growth and a notable rise in disposable income, contributing to increased healthcare spending across a broader population base. Additional growth drivers include the rising incidence and prevalence of acute and chronic diseases, modernization of healthcare infrastructure, and the growing adoption of advanced diagnostic technologies, particularly in rural areas. These factors are anticipated to create substantial growth opportunities for blood gas analyzer companies in the Asia Pacific.

The breakup of the profile of primary participants in the blood gas analyzer market:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: C-level - 28%, D-level - 15%, and Others - 57%
  • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America - 6%, and Middle East & Africa- 4%

The key players in this market are Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Siemens Healthineers AG (Germany), Werfen S.A. (Spain), Nova Biomedical (US), Medica Corporation (US), Techno Medica Co., Ltd. (Japan), IDEXX Laboratories, Inc. (US), i-SENS, Inc. (South Korea), EDAN Instruments, Inc. (China), Guangzhou Wondfo Biotech Co., Ltd. (China), Labtron Equipment Ltd. (UK), Convergent Technologies GmbH & Co. KG (Germany), Erba Group (Czech Republic), ESCHWEILER GmbH & Co. KG (Germany), Sensa Core Medical Instrumentation Pvt. Ltd. (India), Chengdu Seamaty Technology Co., Ltd. (China), Labdex Ltd. (UK), Meizhou Cornley High-Tech Co., Ltd. (China), Paramedical Srl (Italy), Eaglenos Sciences, Inc. (China), B&E Bio-technology Co., Ltd. (US), Labnics Ltd. (UK) and Fison Instruments Ltd.(UK).

Research Coverage:

This research report categorizes the blood gas analyzer market by product (consumables, analyzers, and services), by type of testing (point-of-care testing and conventional testing), by sample type (arterial blood, venous blood, and capillary blood), by application (critical care management, respiratory care, emergency care management, and other applications), by end user (hospitals & ASCs, clinics, and other end users), and region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, opportunities, and challenges influencing the growth of the blood gas analyzer market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies, acquisitions, and agreements, product & service launches, and recent developments associated with the blood gas analyzer market. This report covers a competitive analysis of upcoming startups in the blood gas analyzer market ecosystem.

Reasons to buy this report:

The report will help the market leaders/new entrants with information on the closest approximations of the revenue numbers for the overall blood gas analyzer market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, opportunities, and challenges.

The report provides insights into the following pointers:

  • Analysis of key drivers, such as (rising incidence and prevalence of chronic and acute conditions, advancements in blood gas analyzer technology, inadequacy of alternative techniques, growing demand for point of care blood gas analyzers), opportunities (growth opportunities in developing countries, rising ICU and emergency department admissions), restraints (unfavorable reimbursement policies, complex operations and interpretation of data), and challenges (availability of refurbished analyzers, lack of data analysis software) influencing the growth of the blood gas analyzer market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the blood gas analyzer market
  • Market Development: Comprehensive information about lucrative markets-the report analyzes the blood gas analyzer market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the blood gas analyzer market

Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Danaher Corporation (US), Werfen S.A. (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), and Siemens Healthineers AG (Germany), among others

Product Code: MD 4435

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 KEY STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH APPROACH
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key secondary sources
      • 2.2.1.2 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Primary sources
      • 2.2.2.2 Key data from primary sources
      • 2.2.2.3 Key industry insights
      • 2.2.2.4 Breakdown of primary interviews
  • 2.3 MARKET SIZE ESTIMATION
    • 2.3.1 BOTTOM-UP APPROACH
      • 2.3.1.1 Approach 1: Company revenue estimation approach
      • 2.3.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.3.1.3 Growth forecast
      • 2.3.1.4 CAGR projections
    • 2.3.2 TOP-DOWN APPROACH
  • 2.4 DATA TRIANGULATION
  • 2.5 MARKET SHARE ASSESSMENT
  • 2.6 RESEARCH ASSUMPTIONS
    • 2.6.1 PARAMETRIC ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
  • 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BLOOD GAS ANALYZERS MARKET OVERVIEW
  • 4.2 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION)
  • 4.3 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2025 VS. 2030 (USD MILLION)
  • 4.4 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
  • 4.5 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • 4.6 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • 4.7 BLOOD GAS ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising incidence and prevalence of chronic and acute conditions
      • 5.2.1.2 Advancements in blood gas analyzer technology
      • 5.2.1.3 Inadequacy of alternative techniques
      • 5.2.1.4 Growing demand for point-of-care blood gas analyzers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable reimbursement policies
      • 5.2.2.2 Complex operations & interpretation of data
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in developing countries
      • 5.2.3.2 Rising ICU and emergency department admissions
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Availability of refurbished analyzers
      • 5.2.4.2 Lack of data analysis software
  • 5.3 PRICING ANALYSIS
    • 5.3.1 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, 2023-2025
    • 5.3.2 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY KEY PLAYER, 2023-2025
    • 5.3.3 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY REGION, 2023-2025
  • 5.4 PATENT ANALYSIS
    • 5.4.1 LIST OF MAJOR PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 SUPPLY CHAIN ANALYSIS
  • 5.7 TRADE ANALYSIS
    • 5.7.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS
    • 5.7.2 IMPORT DATA (HS CODE 9027)
    • 5.7.3 EXPORT DATA (HS CODE 9027)
  • 5.8 ECOSYSTEM ANALYSIS
    • 5.8.1 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM
  • 5.9 PORTER'S FIVE FORCES ANALYSIS
    • 5.9.1 THREAT OF NEW ENTRANTS
    • 5.9.2 THREAT OF SUBSTITUTES
    • 5.9.3 BARGAINING POWER OF BUYERS
    • 5.9.4 BARGAINING POWER OF SUPPLIERS
    • 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 REGULATORY ANALYSIS
    • 5.10.1 REGULATORY LANDSCAPE
      • 5.10.1.1 North America
        • 5.10.1.1.1 US
        • 5.10.1.1.2 Canada
      • 5.10.1.2 Europe
        • 5.10.1.2.1 Germany
        • 5.10.1.2.2 UK
        • 5.10.1.2.3 France
        • 5.10.1.2.4 Italy
      • 5.10.1.3 Asia Pacific
        • 5.10.1.3.1 China
        • 5.10.1.3.2 Japan
        • 5.10.1.3.3 India
      • 5.10.1.4 Latin America
        • 5.10.1.4.1 Brazil
        • 5.10.1.4.2 Mexico
      • 5.10.1.5 Middle East
      • 5.10.1.6 Africa
    • 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Electrochemical sensors
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Optical sensors
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Microfluidics
  • 5.12 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.14.2 BUYING CRITERIA
  • 5.15 INVESTMENT & FUNDING SCENARIO
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 CASE STUDY 1: ROLE OF BLOOD GAS ANALYSIS IN EMERGENCY AND CRITICAL CARE
    • 5.16.2 CASE STUDY 2: EVALUATION OF A HANDHELD BLOOD GAS ANALYZER IN INTENSIVE CARE SETTINGS
    • 5.16.3 CASE STUDY 3: ROLE OF QUALITY MANAGEMENT SYSTEMS IN BLOOD GAS ANALYSIS
  • 5.17 IMPACT OF AI/GENERATIVE AI ON BLOOD GAS ANALYZERS MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 MARKET POTENTIAL OF AI
    • 5.17.3 AI USE CASES
    • 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE
    • 5.17.5 FUTURE OF AI IN BLOOD GAS ANALYZERS MARKET
  • 5.18 IMPACT OF 2025 US TARIFFS ON BLOOD GAS ANALYZERS MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 KEY TARIFF RATES
    • 5.18.3 PRICE IMPACT ANALYSIS
    • 5.18.4 KEY IMPACT ON COUNTRY/REGION
      • 5.18.4.1 North America
      • 5.18.4.2 Europe
      • 5.18.4.3 Asia Pacific
    • 5.18.5 IMPACT ON END-USE INDUSTRIES
      • 5.18.5.1 Hospitals & ASCs
      • 5.18.5.2 Clinics

6 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    • 6.2.1 RECURRING USE OF CONSUMABLES TO DRIVE MARKET GROWTH
  • 6.3 ANALYZERS
    • 6.3.1 TECHNOLOGICAL ADVANCEMENTS IN ANALYZERS TO DRIVE ADOPTION
  • 6.4 SERVICES
    • 6.4.1 INCREASING FOCUS ON OPERATIONAL EFFICIENCY TO PROPEL MARKET EXPANSION

7 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING

  • 7.1 INTRODUCTION
  • 7.2 POINT-OF-CARE TESTING
    • 7.2.1 IMPROVED USABILITY AND INNOVATIONS IN POC ANALYZERS TO BOOST ADOPTION OF POINT-OF-CARE TESTING
  • 7.3 CONVENTIONAL TESTING
    • 7.3.1 GROWING FOCUS ON AUTOMATION AND ACCURACY TO STRENGTHEN MARKET GROWTH

8 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE

  • 8.1 INTRODUCTION
  • 8.2 ARTERIAL BLOOD
    • 8.2.1 HIGH UTILIZATION IN CRITICAL CARE SETTINGS TO SUPPORT MARKET GROWTH
  • 8.3 VENOUS BLOOD
    • 8.3.1 REDUCED INVASIVENESS OF VENOUS BLOOD SAMPLING TO BOOST MARKET ADOPTION
  • 8.4 CAPILLARY BLOOD
    • 8.4.1 RISING DEMAND FOR PATIENT-CENTRIC CAPILLARY SAMPLING TO DRIVE MARKET EXPANSION

9 BLOOD GAS ANALYZERS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 CRITICAL CARE MANAGEMENT
    • 9.2.1 INCREASING BURDEN OF ACUTE CRITICAL ILLNESSES TO SUPPORT MARKET EXPANSION
  • 9.3 RESPIRATORY CARE
    • 9.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH
  • 9.4 EMERGENCY CARE MANAGEMENT
    • 9.4.1 INCREASING EMERGENCY DEPARTMENT VISITS TO PROPEL DEMAND FOR BLOOD GAS ANALYZERS
  • 9.5 OTHER APPLICATIONS

10 BLOOD GAS ANALYZERS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS & ASCS
    • 10.2.1 EXPANDING HEALTHCARE INFRASTRUCTURE TO SPEED UP MARKET GROWTH
  • 10.3 CLINICS
    • 10.3.1 GROWING USE OF POINT-OF-CARE BLOOD GAS ANALYZERS TO SUPPORT MARKET GROWTH
  • 10.4 OTHER END USERS

11 BLOOD GAS ANALYZERS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 11.2.2 US
      • 11.2.2.1 Increasing prevalence of chronic & respiratory diseases to drive market
    • 11.2.3 CANADA
      • 11.2.3.1 Rising demand for real-time diagnostics tools to drive market growth
  • 11.3 EUROPE
    • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 11.3.2 GERMANY
      • 11.3.2.1 Favorable government policies to propel market growth
    • 11.3.3 UK
      • 11.3.3.1 Rising emergency department visits to drive market growth
    • 11.3.4 FRANCE
      • 11.3.4.1 Enhanced healthcare policies and strategic investments in diagnostics to boost market growth
    • 11.3.5 ITALY
      • 11.3.5.1 Growing chronic disease incidence and government initiatives to boost Italy's blood gas analyzers market
    • 11.3.6 SPAIN
      • 11.3.6.1 Growing public health initiatives to augment market growth
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 11.4.2 CHINA
      • 11.4.2.1 Healthcare infrastructure development and disease burden to support market
    • 11.4.3 JAPAN
      • 11.4.3.1 Well-developed healthcare system and high geriatric population to aid market growth
    • 11.4.4 INDIA
      • 11.4.4.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth
    • 11.4.5 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 11.5.2 BRAZIL
      • 11.5.2.1 Universal healthcare access to drive adoption in Brazil
    • 11.5.3 MEXICO
      • 11.5.3.1 Rising medical tourism to create strong demand for advanced diagnostic solutions
    • 11.5.4 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 11.6.2 KINGDOM OF SAUDI ARABIA
      • 11.6.2.1 Rising government healthcare expenditure to boost market
    • 11.6.3 UAE
      • 11.6.3.1 Improvements in healthcare infrastructure to support growth
    • 11.6.4 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN BLOOD GAS ANALYZERS MARKET
  • 12.3 REVENUE ANALYSIS, 2020-2024
  • 12.4 MARKET SHARE ANALYSIS, 2024
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Region footprint
      • 12.5.5.3 Product & service footprint
      • 12.5.5.4 Type of testing footprint
      • 12.5.5.5 Sample type footprint
  • 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
      • 12.6.5.1 Detailed list of key startups/SMEs
      • 12.6.5.2 Competitive benchmarking of startups/SMEs (1/2)
      • 12.6.5.3 Competitive benchmarking of startups/SMEs (2/2)
  • 12.7 COMPANY VALUATION & FINANCIAL METRICS
    • 12.7.1 FINANCIAL METRICS
    • 12.7.2 COMPANY VALUATION
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT/SERVICE LAUNCHES
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 DANAHER CORPORATION
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Deals
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Key strengths
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses & competitive threats
    • 13.1.2 WERFEN S.A.
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product/Service launches
        • 13.1.2.3.2 Expansions
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Key strengths
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses & competitive threats
    • 13.1.3 SIEMENS HEALTHINEERS AG
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Expansions
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Key strengths
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses & competitive threats
    • 13.1.4 F. HOFFMANN-LA ROCHE LTD.
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Expansions
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Key strengths
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses & competitive threats
    • 13.1.5 ABBOTT LABORATORIES
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Services offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Key strengths
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses & competitive threats
    • 13.1.6 NOVA BIOMEDICAL
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product/Service launches
        • 13.1.6.3.2 Deals
        • 13.1.6.3.3 Expansions
    • 13.1.7 MEDICA CORPORATION
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Services offered
    • 13.1.8 TECHNO MEDICA CO., LTD.
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Services offered
    • 13.1.9 IDEXX LABORATORIES, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Services offered
    • 13.1.10 I-SENS, INC.
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Services offered
  • 13.2 OTHER PLAYERS
    • 13.2.1 EDAN INSTRUMENTS, INC.
    • 13.2.2 GUANGZHOU WONDFO BIOTECH CO., LTD.
    • 13.2.3 LABTRON EQUIPMENT LTD.
    • 13.2.4 CONVERGENT TECHNOLOGIES GMBH & CO. KG
    • 13.2.5 ERBA GROUP
    • 13.2.6 ESCHWEILER GMBH & CO.KG
    • 13.2.7 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD.
    • 13.2.8 CHENGDU SEAMATY TECHNOLOGY CO., LTD.
    • 13.2.9 LABDEX LTD.
    • 13.2.10 MEIZHOU CORNLEY HIGH-TECH CO., LTD.
    • 13.2.11 PARAMEDICAL SRL
    • 13.2.12 EAGLENOS SCIENCES, INC.
    • 13.2.13 B&E BIO-TECHNOLOGY CO., LTD.
    • 13.2.14 LABNICS LTD.
    • 13.2.15 FISON INSTRUMENTS LTD.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS
Product Code: MD 4435

List of Tables

  • TABLE 1 BLOOD GAS ANALYZERS MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 BLOOD GAS ANALYZERS MARKET: KEY DATA FROM PRIMARY SOURCES
  • TABLE 3 AVERAGE SELLING PRICING TREND OF BLOOD GAS BY PRODUCT AFTER ANALYZER, 2023-2025
  • TABLE 4 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY KEY PLAYER, 2023-2025
  • TABLE 5 AVERAGE SELLING PRICE TREND OF BLOOD GAS ANALYZERS, BY REGION, 2023-2025
  • TABLE 6 LIST OF MAJOR PATENTS, 2023-2025
  • TABLE 7 IMPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 8 EXPORT DATA FOR INSTRUMENTS AND APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE 9027), BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 9 BLOOD GAS ANALYZERS MARKET: ROLE IN ECOSYSTEM
  • TABLE 11 CLASSIFICATION OF IVD DEVICES IN EUROPE
  • TABLE 12 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
  • TABLE 15 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
  • TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BLOOD GAS ANALYZERS (%)
  • TABLE 20 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS
  • TABLE 21 KEY COMPANIES IMPLEMENTING AI
  • TABLE 22 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 23 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 24 CONSUMABLES OFFERED BY KEY MARKET PLAYERS
  • TABLE 25 BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 26 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 27 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 29 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONSUMABLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 31 ANALYZERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 32 BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 33 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 34 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 36 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ANALYZERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 38 BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 40 EUROPE: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 42 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR SERVICES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 44 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 45 KEY POINT-OF-CARE TESTING DEVICES AVAILABLE IN MARKET
  • TABLE 46 BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 48 EUROPE: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 49 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 50 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 51 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR POINT-OF-CARE TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 52 KEY CONVENTIONAL TESTING DEVICES AVAILABLE IN MARKET
  • TABLE 53 BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 55 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 57 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 58 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CONVENTIONAL TESTING, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 59 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 60 SOME ARTERIAL BLOOD-BASED PRODUCTS AVAILABLE IN MARKET
  • TABLE 61 BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 EUROPE: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 64 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 65 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 66 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR ARTERIAL BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 67 SOME VENOUS BLOOD-BASED PRODUCTS AVAILABLE IN MARKET
  • TABLE 68 BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 70 EUROPE: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 71 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 72 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 73 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR VENOUS BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 74 SOME CAPILLARY BLOOD-BASED PRODUCTS AVAILABLE IN MARKET
  • TABLE 75 BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 76 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 77 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 79 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 80 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CAPILLARY BLOOD SAMPLES, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 81 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 82 BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 83 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 84 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 86 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CRITICAL CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 88 BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 89 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 90 EUROPE: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 92 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR RESPIRATORY CARE, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 94 BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 96 EUROPE: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 98 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR EMERGENCY CARE MANAGEMENT, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 100 BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 102 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 104 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 106 BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 107 BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 108 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 109 EUROPE: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 111 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 112 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR HOSPITALS & ASCS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 113 BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 114 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 115 EUROPE: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 116 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 117 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 118 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR CLINICS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 119 BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 120 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 121 EUROPE: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 123 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 125 BLOOD GAS ANALYZERS MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 126 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 127 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 128 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 130 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 131 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: MACROECONOMIC INDICATORS
  • TABLE 133 US: NUMBER OF EMERGENCY DEPARTMENT VISITS, 2023-2030
  • TABLE 134 US: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 135 US: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 136 US: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 US: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 138 US: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 139 CANADA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 140 CANADA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 141 CANADA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 CANADA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 143 CANADA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 144 EUROPE: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 145 EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 146 EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 147 EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 149 EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 150 EUROPE: MACROECONOMIC INDICATORS
  • TABLE 151 GERMANY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 152 GERMANY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 153 GERMANY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 GERMANY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 155 GERMANY: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 156 UK: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 157 UK: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 158 UK: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 UK: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 160 UK: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 161 FRANCE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 162 FRANCE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 163 FRANCE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 FRANCE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 165 FRANCE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 166 ITALY: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 167 ITALY: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 168 ITALY: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 169 ITALY: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 170 ITALY: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 171 SPAIN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 172 SPAIN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 173 SPAIN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 SPAIN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 175 SPAIN: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 176 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 177 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 178 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 179 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 180 REST OF EUROPE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 181 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 182 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 183 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 184 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 185 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 186 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 187 ASIA PACIFIC: MACROECONOMIC INDICATORS
  • TABLE 188 CHINA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 189 CHINA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 190 CHINA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 CHINA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 192 CHINA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 193 JAPAN: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 194 JAPAN: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 195 JAPAN: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 JAPAN: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 197 JAPAN: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 198 INDIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 199 INDIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 200 INDIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 201 INDIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 202 INDIA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 203 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 204 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 205 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 207 REST OF ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 208 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 209 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 210 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 211 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 212 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 213 LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 214 LATIN AMERICA: MACROECONOMIC INDICATORS
  • TABLE 215 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 216 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 217 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 218 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 219 BRAZIL: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 220 MEXICO: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 221 MEXICO: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 222 MEXICO: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 MEXICO: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 224 MEXICO: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 225 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 226 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 232 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 233 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 234 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
  • TABLE 237 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 238 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 239 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 241 KINGDOM OF SAUDI ARABIA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 242 UAE: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 243 UAE: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 244 UAE: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 245 UAE: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 246 UAE: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 247 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2023-2030 (USD MILLION)
  • TABLE 248 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2023-2030 (USD MILLION)
  • TABLE 249 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
  • TABLE 251 REST OF MIDDLE EAST & AFRICA: BLOOD GAS ANALYZERS MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 252 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN BLOOD GAS ANALYZERS MARKET, JANUARY 2022-SEPTEMBER 2025
  • TABLE 253 BLOOD GAS ANALYZERS MARKET: DEGREE OF COMPETITION
  • TABLE 254 BLOOD GAS ANALYZERS MARKET: REGION FOOTPRINT
  • TABLE 255 BLOOD GAS ANALYZERS MARKET: PRODUCT & SERVICE FOOTPRINT
  • TABLE 256 BLOOD GAS ANALYZERS MARKET: TYPE OF TESTING FOOTPRINT
  • TABLE 257 BLOOD GAS ANALYZERS MARKET: SAMPLE TYPE FOOTPRINT
  • TABLE 258 BLOOD GAS ANALYZERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 259 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2)
  • TABLE 260 BLOOD GAS ANALYZERS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2)
  • TABLE 261 BLOOD GAS ANALYZERS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 262 BLOOD GAS ANALYZERS MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 263 BLOOD GAS ANALYZERS MARKET: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 264 DANAHER CORPORATION: COMPANY OVERVIEW
  • TABLE 265 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 266 DANAHER CORPORATION: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 267 WERFEN S.A.: COMPANY OVERVIEW
  • TABLE 268 WERFEN S.A.: PRODUCTS/SERVICES OFFERED
  • TABLE 269 WERFEN S.A.: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 270 WERFEN S.A.: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 271 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 272 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED
  • TABLE 273 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 274 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 275 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
  • TABLE 276 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 277 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 278 ABBOTT LABORATORIES: COMPANY OVERVIEW
  • TABLE 279 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
  • TABLE 280 NOVA BIOMEDICAL: COMPANY OVERVIEW
  • TABLE 281 NOVA BIOMEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 282 NOVA BIOMEDICAL: PRODUCT/SERVICE LAUNCHES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 283 NOVA BIOMEDICAL: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 284 NOVA BIOMEDICAL: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 285 MEDICA CORPORATION: COMPANY OVERVIEW
  • TABLE 286 MEDICA CORPORATION: PRODUCTS/SERVICES OFFERED
  • TABLE 287 TECHNO MEDICA CO., LTD.: COMPANY OVERVIEW
  • TABLE 288 TECHNO MEDICA CO., LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 289 IDEXX LABORATORIES, INC.: COMPANY OVERVIEW
  • TABLE 290 IDEXX LABORATORIES, INC: PRODUCTS/SERVICES OFFERED
  • TABLE 291 I-SENS, INC.: COMPANY OVERVIEW
  • TABLE 292 I-SENS, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 293 EDAN INSTRUMENTS, INC.: COMPANY OVERVIEW
  • TABLE 294 GUANGZHOU WONDFO BIOTECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 295 LABTRON EQUIPMENT LTD.: COMPANY OVERVIEW
  • TABLE 296 CONVERGENT TECHNOLOGIES GMBH & CO. KG: COMPANY OVERVIEW
  • TABLE 297 ERBA GROUP: COMPANY OVERVIEW
  • TABLE 298 ESCHWEILER GMBH & CO.KG: COMPANY OVERVIEW
  • TABLE 299 SENSA CORE MEDICAL INSTRUMENTATION PVT. LTD.: COMPANY OVERVIEW
  • TABLE 300 CHENGDU SEAMATY TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 301 LABDEX LTD.: COMPANY OVERVIEW
  • TABLE 302 MEIZHOU CORNLEY HIGH-TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 303 PARAMEDICAL SRL: COMPANY OVERVIEW
  • TABLE 304 EAGLENOS SCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 305 B&E BIO-TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
  • TABLE 306 LABNICS LTD.: COMPANY OVERVIEW
  • TABLE 307 FISON INSTRUMENTS LTD.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 BLOOD GAS ANALYZERS MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 BLOOD GAS ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
  • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 8 BLOOD GAS ANALYZERS MARKET: TOP-DOWN APPROACH
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 BLOOD GAS ANALYZERS MARKET: RESEARCH ASSUMPTIONS
  • FIGURE 11 BLOOD GAS ANALYZERS MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 12 BLOOD GAS ANALYZERS MARKET, BY TYPE OF TESTING, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 BLOOD GAS ANALYZERS MARKET, BY SAMPLE TYPE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 BLOOD GAS ANALYZERS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 BLOOD GAS ANALYZERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 BLOOD GAS ANALYZERS MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 GROWING BURDEN OF CHRONIC AND ACUTE DISEASES AND ADVANCEMENTS IN POINT-OF-CARE DIAGNOSTICS TO DRIVE MARKET
  • FIGURE 18 CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 19 POINT-OF-CARE TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 20 ARTERIAL BLOOD SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 CRITICAL CARE MANAGEMENT SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 22 HOSPITALS & ASCS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 23 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN BLOOD GAS ANALYZERS MARKET DURING FORECAST PERIOD
  • FIGURE 24 BLOOD GAS ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 25 PATENT ANALYSIS FOR BLOOD GAS ANALYZERS (JANUARY 2014-DECEMBER 2024)
  • FIGURE 26 VALUE CHAIN ANALYSIS OF BLOOD GAS ANALYZERS MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES
  • FIGURE 27 BLOOD GAS ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 28 BLOOD GAS ANALYZERS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 29 BLOOD GAS ANALYZERS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 BLOOD GAS ANALYZERS MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BLOOD GAS ANALYZERS
  • FIGURE 32 KEY BUYING CRITERIA FOR BLOOD GAS ANALYZERS
  • FIGURE 33 NUMBER OF DEALS & FUNDING ACTIVITIES IN BLOOD GAS ANALYZERS MARKET (2021-2024)
  • FIGURE 34 MARKET POTENTIAL OF AI IN BLOOD GAS ANALYZERS MARKET
  • FIGURE 35 NORTH AMERICA: BLOOD GAS ANALYZERS MARKET SNAPSHOT
  • FIGURE 36 ASIA PACIFIC: BLOOD GAS ANALYZERS MARKET SNAPSHOT
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN BLOOD GAS ANALYZERS MARKET (2020-2024)
  • FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN BLOOD GAS ANALYZERS MARKET (2024)
  • FIGURE 39 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 40 BLOOD GAS ANALYZERS MARKET: COMPANY FOOTPRINT
  • FIGURE 41 BLOOD GAS ANALYZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 44 BLOOD GAS ANALYZERS MARKET: BRAND COMPARISON FOR ANALYZERS
  • FIGURE 45 DANAHER CORPORATION: COMPANY SNAPSHOT (2024)
  • FIGURE 46 WERFEN S.A: COMPANY SNAPSHOT (2024)
  • FIGURE 47 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024)
  • FIGURE 48 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024)
  • FIGURE 49 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024)
  • FIGURE 50 TECHNO MEDICA CO., LTD.: COMPANY SNAPSHOT (2025)
  • FIGURE 51 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 52 I-SENS, INC.: COMPANY SNAPSHOT (2024)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!